1. Home
  2. RCEL vs HCAT Comparison

RCEL vs HCAT Comparison

Compare RCEL & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$5.41

Market Cap

132.0M

Sector

Health Care

ML Signal

HOLD

Logo Health Catalyst Inc

HCAT

Health Catalyst Inc

HOLD

Current Price

$1.73

Market Cap

152.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCEL
HCAT
Founded
N/A
2008
Country
United States
United States
Employees
226
N/A
Industry
Medical/Dental Instruments
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
132.0M
152.1M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
RCEL
HCAT
Price
$5.41
$1.73
Analyst Decision
Buy
Hold
Analyst Count
4
11
Target Price
$7.17
$4.25
AVG Volume (30 Days)
196.9K
877.4K
Earning Date
01-01-0001
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
44.98
EPS
N/A
N/A
Revenue
N/A
$306,584,000.00
Revenue This Year
$21.69
$3.30
Revenue Next Year
$49.58
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.60
52 Week Low
$3.22
$1.67
52 Week High
$10.28
$5.09

Technical Indicators

Market Signals
Indicator
RCEL
HCAT
Relative Strength Index (RSI) 69.93 33.70
Support Level $3.33 N/A
Resistance Level $6.16 $2.45
Average True Range (ATR) 0.34 0.13
MACD 0.07 -0.02
Stochastic Oscillator 87.69 6.82

Price Performance

Historical Comparison
RCEL
HCAT

About RCEL Avita Medical Inc.

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Share on Social Networks: